Dealing with these decisions isn’t easy while undergoing cancer treatment. But yes, it’s completely understandable to ...

Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early ...

Belgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced the submission of an extension of ...

A genetics research laboratory has reached a significant milestone in its efforts to recruit 1,000 volunteers for a prostate ...

He identified age as the leading risk factor, noting that cases are rarely seen in men under 40. Genetics and family history ...

OUR resident specialist and NHS GP, Dr Zoe Williams, shares her expert advice. Today, Dr Zoe helps a reader who is concerned ...

Australians aged in their 30s and 40s are experiencing unprecedented and in some cases world-leading rates of at least 10 ...

This National Cancer Survivors Season, jscreen, a national non-profit public health initiative dedicated to preventing ...

Department of Urology is seeing 50-60 prostate cancer patients daily, with most being men aged 45 and above. Dr. Porferio ...

Johnson & Johnson has announced the submission of an extension of indication application to the European Medicines Agency (EMA) seeking approval of Akeega (niraparib/abiraterone acetate) with ...

CariGenetics reached a milestone in an ongoing cancer study, “surpassing the 25% mark of its regional 1000-men study in ...

Using an inexpensive electrode coated with DNA, MIT researchers have designed disposable diagnostics that could be adapted to ...